BioInvent International
28.40 SEK
+0.53 %
Less than 1K followers
BINV
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+0.53 %
-8.39 %
-2.91 %
-25.36 %
-26.23 %
-30.31 %
-21.76 %
-36.18 %
-97.02 %
BioInvent International is a biotechnology company focused on the development of innovative antibody therapies for cancer treatment. The company researches new treatments that can improve patient outcomes and quality of life. The company operates globally with a presence in international markets. BioInvent International was founded in 1983 and is headquartered in Lund.
Read moreMarket cap
1.87B SEK
Turnover
977.13K SEK
Revenue
44.69M
EBIT %
-1,054.06 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26/2
2026
Annual report '25
29/4
2026
Interim report Q1'26
29/4
2026
General meeting '26
All
Webcasts
Press releases
ShowingAll content types
BioStock: Dubbla framgångar för BioInvent på ASH och plattformvalidering
BioInvent presenterar imponerande responsdata från den pågående fas 2a-studien av trippelkombinationen BI-1206, rituximab och Calquence i r/r NHL på ASH 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools